IL206273A0 - Composition comprising superoxide dismutase and carboxy methyl beta-1,3 glucan - Google Patents
Composition comprising superoxide dismutase and carboxy methyl beta-1,3 glucanInfo
- Publication number
- IL206273A0 IL206273A0 IL206273A IL20627310A IL206273A0 IL 206273 A0 IL206273 A0 IL 206273A0 IL 206273 A IL206273 A IL 206273A IL 20627310 A IL20627310 A IL 20627310A IL 206273 A0 IL206273 A0 IL 206273A0
- Authority
- IL
- Israel
- Prior art keywords
- glucan
- composition
- superoxide dismutase
- carboxy methyl
- methyl beta
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
- C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
- C12Y115/01001—Superoxide dismutase (1.15.1.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IT2007/000914 WO2009084044A1 (en) | 2007-12-27 | 2007-12-27 | Composition comprising superoxide dismutase and carboxv methyl beta-1,3 glucan |
Publications (1)
Publication Number | Publication Date |
---|---|
IL206273A0 true IL206273A0 (en) | 2010-12-30 |
Family
ID=39731080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL206273A IL206273A0 (en) | 2007-12-27 | 2010-06-09 | Composition comprising superoxide dismutase and carboxy methyl beta-1,3 glucan |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2229180A1 (en) |
IL (1) | IL206273A0 (en) |
WO (1) | WO2009084044A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1277707B1 (en) * | 1995-12-22 | 1997-11-11 | Chemedica Sa | OPHTHALMIC FORMULATION BASED ON SODIUM HYALURONATE FOR USE IN OCULAR SURGERY |
WO1999033439A1 (en) * | 1997-12-24 | 1999-07-08 | Shaklee Corporation | Composition with high efficiency skin protection from damaging effects of ultraviolet light |
US7011845B2 (en) * | 2000-05-09 | 2006-03-14 | Mcp Hahnemann University | β-glucans encapsulated in liposomes |
ATE347398T1 (en) * | 2002-06-10 | 2006-12-15 | Dmg Italia Srl | CARBOXY METHYL BETA-1,3 GLUCAN CONTAINING OPHTHALMIC SOLUTION |
-
2007
- 2007-12-27 EP EP07866845A patent/EP2229180A1/en not_active Withdrawn
- 2007-12-27 WO PCT/IT2007/000914 patent/WO2009084044A1/en active Application Filing
-
2010
- 2010-06-09 IL IL206273A patent/IL206273A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009084044A1 (en) | 2009-07-09 |
EP2229180A1 (en) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283205A (en) | Cell binding agent drug conjugates, compositions comprising the same and uses thereof | |
PL2271725T3 (en) | Compositions comprising 2,3,3,3-tetrafluoropropene and 1,1,1-trifluoropropene | |
IL208937A0 (en) | Cell binding agent cytotoxic drug conjugates, compositions comprising the same and uses thereof | |
PL2899247T3 (en) | Compositions comprising 2,3,3,3-tetrafluoropropene and hydrocarbons and uses thereof | |
EP2153838A4 (en) | Anti-norovirus agent, and composition comprising the same | |
IL230759A0 (en) | Substituted acylanilide, composition comprising it and uses thereof | |
IL213150A (en) | Truncated soluble ph20 polypeptides, conjugates and compositions comprising truncated soluble ph20 polypeptides and uses thereof | |
GB0601143D0 (en) | Uses, methods and compositions | |
EP2287234A4 (en) | Cellulose powder having excellent segregation preventive effect, and compositions thereof | |
EP2076604A4 (en) | Glp-2 mimetibodies, polypeptides, compositions, methods and uses | |
IL211762A0 (en) | Pegylated opiods, compositions comprising the same and uses thereof | |
IL212836A0 (en) | Azaquinolinone derivatives, compositions comprising the same and uses thereof | |
HK1144772A1 (en) | Protopanaxadiol-type ginsenoside compositions and uses thereof | |
EP2116224A4 (en) | Cosmetic composition | |
EP2064335A4 (en) | Molecules with reduced half-lives, compositions and uses thereof | |
IL212278A0 (en) | Morpholinopurine derivatives, compositions comprising the same and uses thereof | |
IL205966A0 (en) | Oligomer-tricyclic conjugates, compositions comprising the same and uses thereof | |
EP1984004A4 (en) | Therapy-enhancing glucan | |
GB0706077D0 (en) | Methods, Compositions and uses thereof | |
HK1127570A1 (en) | Improvements in, or relating to, particle cassettes | |
EP2245091A4 (en) | Nanoparticle dispersion, compositions containing the same, and articles made therefrom | |
EP2217527A4 (en) | Nanocomposites,polymer compositions comprising the same and preparation methods thereof | |
GB2434370B (en) | Polymer electrolyte composition and application thereof | |
EP1998753A4 (en) | High-deposition compositions and uses thereof | |
EP2247303A4 (en) | Haemostasis- modulating compositions and uses therefor |